/* Product view custom css */
Penam Laboratories Ltd

Penam Laboratories Ltd (Transfer Only in NSDL A/C)

Master

Penam Laboratories Ltd (Transfer Only in NSDL A/C)

Face Value 10
ISIN No INE06AW01010

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
1011768 10 500 Rs 920.00 Rs 460,000.00 Rs Demat 50
1011767 10 500 Rs 930.00 Rs 465,000.00 Rs Demat 50

Company Information


Penam Laboratories Limited Unlisted Shares


Board of Directors

Managing Director

: Mr. Surender Kumar Ajmani

Independent Director

: Mr. Arun Mittal


Background:

Penam Laboratories Ltd. (PLL) is engaged in the manufacturing, including contract manufacturing, of bulk drugs, active Pharmaceutical Ingredients (APIs), API intermediates and formulations for the domestic as well as international markets, including semi -regulated markets. The Company produces the Semi-Synthetic Penicillin (SSP) range of beta-lactam antibiotics in oral form, and has forward integration to make formulations of the APIs produced, and also has backward integration to manufacture in -house the intermediates for such APIs.


Registered Office:

F-223, New Rajinder Nagar, New Delhi-110060


INCORPORATION YEAR

: 1989

WEBSITE

: www.penam.in

EMAIL

: info@penam.in

CIN NO

: U24231DL1989PLC037287

ISIN NO.

: INE06AW01010

SECTOR

: Healthcare

FACE VALUE

: 10

PROMOTER HOLDING

: 95.23%


Financial Information for Last 3 Years (Rupees in Crore)

Particulars

2024

2023

2022

Equity Capital

5.17

5.17

5.17

Reserve & Surplus

451.42

397.81

353.59

Net worth

456.58

402.97

358.76

Book Value Per share Rs.

883.62

779.87

694.30

Total Income

552.80

519.02

351.70

Profit After Tax

53.70

44.12

32.30

Earnings Per Share Rs.

103.75

85.57

62.65


Annual Report Penam Laboratories Limited Unlisted Shares

Annual Report of Penam Laboratories Limited - 2024

Annual Report of Penam Laboratories Limited - 2022

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy